Cigna Investments Inc Arrowhead Pharmaceuticals, Inc. Transaction History

Cigna Investments Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$58.38 - $84.96 $185,940 - $270,597	-3,185 Closed	0 $0
Q2 2021 Aug 10, 2021	SELL	$62.15 - $90.32 $31,075 - $45,160	-500 Reduced 13.57%	3,185 $264,000
Q1 2021 May 10, 2021	BUY	$61.35 - $90.47 $4,601 - $6,785	75 Added 2.08%	3,685 $244,000
Q4 2020 Feb 11, 2021	BUY	$43.82 - $85.37 $158,190 - $308,185	3,610 New	3,610 $276,000

295

90.8M

155K

426K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $1.96B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Cigna Investments Inc , based on Form 13F filings with the SEC.

Stay updated on Cigna Investments Inc with notifications on news.